Valuation · US stocks

ArriVent BioPharma, Inc. (AVBP) valuation

As of 2026-11-18, ArriVent BioPharma, Inc. trades at $10.90, below the lowest fair-value bound of its 1, 3 and 5-year windows.

Price
$10.90
Day change
+1.96%
Market cap
$759.00M
Sector
—
Valuation
Below band
Fair value
Sign up free to see the fair value and gap
As of
2026-11-18
Open the full valuation in Wave Radar

Options

Options price a move of ±63.89% to the 2027-04-16 expiry (implied volatility 99.17%). AVBP gamma exposure

Other — stocks

StockPriceMarket capValuation
Warner Bros. Discovery, Inc. Series A WBD$30.95$69.97BAbove band
Roku, Inc. Class A ROKU$160.52$23.93BFair
Arcosa, Inc. ACA$149.18$7.32BAbove band
Black Hills Corporation BKH$80.72$6.45BAbove band
LXP Industrial Trust LXP$61.18$3.61BFair
Atkore Inc ATKR$94.96$3.19BHigh
Medical Properties Trust, Inc. MPT$1.64$2.33BLow
FuelCell Energy, Inc. FCEL$7.76$1.65BHigh
Fluence Energy, Inc. Class A FLNC$4.03$1.42BBelow band
Digital Turbine, Inc. APPS$6.57$1.38BHigh
TripAdvisor, Inc. TRIP$7.22$1.22BFair
BigBear.ai Holdings, Inc. BBAI$1.75$1.15BBelow band

How the valuation band works

Wave Radar estimates a fair-value range from each company's earnings, book value and its own historical P/E and P/B over 1, 3 and 5-year windows. The 1-year window gives the tight range; the widest bounds across all windows give the loose one. "Low" and "High" mean the price has left the tight range; "Below band" and "Above band" mean it has left even the widest one.

Read the method

Figures are generated automatically from Wave Radar's published market data and refresh after each market close.